Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SHC adaptor protein 1 pseudogene 2 (SHC1P2) is annotated as a **pseudogene** related to the SHC1 gene, which encodes the SHC-transforming protein 1—a key adaptor protein linking activated receptor tyrosine kinases to multiple signaling pathways, including those regulating apoptosis, oxidative stress, and cell proliferation[1][3][5]. Unlike SHC1, SHC1P2 does not encode a functional protein and has no documented biological activity, molecular function, or disease role. Pseudogenes generally do not produce proteins; instead, they are remnants of genes that have lost coding potential through mutation or genomic rearrangement. There is no evidence that SHC1P2 acts as a receptor, enzyme, transporter, or other therapeutic target, nor is there any described interaction with drugs, biomarker relevance, or role in disease. **Note:** If your interest is in the functional **SHC1 gene/protein (SHC-transforming protein 1, SHC1)**—a well-studied adaptor protein involved in signal transduction and cancer biology—please clarify, as SHC1 itself has significant biological and clinical relevance[1][2][3][5]. SHC1P2, being a pseudogene, does not share these properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SHC adaptor protein 1 pseudogene 2 (SHC1P2).